Go Pro

Celestica (NYSE:CLS) Stock Rating Upgraded by FBN Securities

Celestica logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • FBN Securities upgraded Celestica to “strong buy,” joining a broad analyst consensus of “Buy.” The consensus price target is $440.50.
  • Celestica reported quarterly EPS of $2.54, beating estimates of $2.29, while revenue reached $4.68 billion and rose 62.4% year over year.
  • Shares opened at $323.47, up 2.1%, but remain below their 52-week high of $474.02. Company insiders sold approximately $73.4 million of stock in the latest quarter.
  • Five stocks we like better than Celestica.

Celestica (NYSE:CLS - Get Free Report) TSE: CLS was upgraded by research analysts at FBN Securities to a "strong-buy" rating in a research note issued to investors on Tuesday, Zacks reports.

Several other analysts have also commented on the stock. Canadian Imperial Bank of Commerce lifted their price objective on shares of Celestica from $480.00 to $500.00 and gave the stock an "outperform" rating in a research report on Wednesday, July 29th. TD set a $430.00 target price on shares of Celestica and gave the company a "buy" rating in a research report on Wednesday. Zacks Research upgraded shares of Celestica from a "hold" rating to a "strong-buy" rating in a research note on Friday, June 26th. Royal Bank Of Canada set a $450.00 price target on shares of Celestica and gave the stock an "outperform" rating in a report on Wednesday, August 26th. Finally, Wall Street Zen downgraded Celestica from a "buy" rating to a "hold" rating in a research note on Sunday, September 6th. Two analysts have rated the stock with a Strong Buy rating and twenty-two have given a Buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Buy" and a consensus price target of $440.50.

View Our Latest Stock Report on Celestica

Celestica Stock Up 2.1%

Shares of NYSE:CLS opened at $323.47 on Tuesday. The company has a market capitalization of $37.19 billion, a PE ratio of 33.62 and a beta of 2.04. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.23 and a quick ratio of 0.68. The business has a fifty day moving average price of $323.56 and a two-hundred day moving average price of $338.09. Celestica has a 1 year low of $227.00 and a 1 year high of $474.02.

Celestica (NYSE:CLS - Get Free Report) TSE: CLS last released its earnings results on Monday, July 27th. The technology company reported $2.54 EPS for the quarter, topping analysts' consensus estimates of $2.29 by $0.25. The company had revenue of $4.68 billion for the quarter, compared to analysts' expectations of $4.30 billion. Celestica had a return on equity of 39.96% and a net margin of 7.16%.The business's revenue for the quarter was up 62.4% compared to the same quarter last year. During the same period in the previous year, the business posted $1.39 EPS. Celestica has set its FY 2026 guidance at 11.300-11.300 EPS and its Q3 2026 guidance at 2.880-3.080 EPS. Analysts forecast that Celestica will post 10.71 earnings per share for the current year.

Insider Activity

In other Celestica news, CEO Robert Mionis sold 98,453 shares of the business's stock in a transaction on Tuesday, August 4th. The shares were sold at an average price of $368.99, for a total transaction of $36,328,172.47. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO Mandeep Chawla sold 16,117 shares of the firm's stock in a transaction on Tuesday, August 4th. The stock was sold at an average price of $369.32, for a total value of $5,952,330.44. Following the completion of the transaction, the chief financial officer directly owned 65,444 shares of the company's stock, valued at $24,169,778.08. The trade was a 19.76% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 199,553 shares of company stock valued at $73,437,196 in the last quarter. Corporate insiders own 1.10% of the company's stock.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Legacy Wealth Managment LLC ID raised its position in shares of Celestica by 14.4% during the first quarter. Legacy Wealth Managment LLC ID now owns 223 shares of the technology company's stock valued at $63,000 after buying an additional 28 shares during the last quarter. Capital Planning LLC grew its stake in Celestica by 3.2% during the first quarter. Capital Planning LLC now owns 1,025 shares of the technology company's stock valued at $289,000 after acquiring an additional 32 shares in the last quarter. PCB Capital LLC increased its holdings in Celestica by 3.5% in the 1st quarter. PCB Capital LLC now owns 995 shares of the technology company's stock valued at $280,000 after acquiring an additional 34 shares during the last quarter. XML Financial LLC lifted its stake in Celestica by 1.5% in the 2nd quarter. XML Financial LLC now owns 2,640 shares of the technology company's stock worth $963,000 after purchasing an additional 40 shares in the last quarter. Finally, Sequoia Financial Advisors LLC lifted its stake in Celestica by 0.9% in the 2nd quarter. Sequoia Financial Advisors LLC now owns 4,363 shares of the technology company's stock worth $1,592,000 after purchasing an additional 40 shares in the last quarter. Institutional investors own 67.38% of the company's stock.

Celestica Company Profile

(Get Free Report)

Celestica Inc NYSE: CLS is a global provider of design, manufacturing, and supply chain solutions for technology companies and other businesses. The company helps customers develop, manufacture, and support complex electronic products and systems, offering services that span product design and engineering, prototyping, printed circuit board assembly, systems integration, testing, supply chain management, and after-market support.

Celestica serves customers across several markets, including communications and cloud infrastructure, aerospace and defense, industrial technology, health technology, and capital equipment.

Featured Stories

Analyst Recommendations for Celestica (NYSE:CLS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Celestica Right Now?

Before you consider Celestica, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Celestica wasn't on the list.

While Celestica currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines